The independent third-party study focused on the inactivation of SARS-CoV-2 using RGF’s proprietary REME HALO® product with PHI- Cell® technology. The testing, performed at the Innovative Bioanalysis Laboratories in Cypress, Calif., looked at neutralizing the virus within the occupied space in the air and on surfaces.
The test procedure used the SARS-CoV-2 virus inside a large chamber (1,280 cu. ft.) representing a real-world air-conditioned office or home. The virus was nebulized into the space simulating a sneeze or cough from an infected person. With the REME HALO® operating inside the chamber the virus was reduced on contact, resulting in a 99.9% reduction of the virus within the simulated real-world space.
The REME HALO® active air purification system testing showed the SARS-CoV-2 virus was significantly neutralized within the occupied space on airborne virus, reducing the risk of person-to-person infection by respiratory particles and aerosols. The REME HALO® is an “active” solution that neutralizes SARS-CoV-2 within the occupied space, eliminating the need for virus particles to travel through the HVAC system filters or UV air purification system. (Source)